Advertisement
Advertisement

PAVM

PAVM logo

PAVmed Inc. Common Stock

6.30
USD
Sponsored
-0.28
-4.18%
Jan 20, 15:57 UTC -5
Closed
exchange

After-Market

6.14

-0.16
-2.54%

PAVM Earnings Reports

Positive Surprise Ratio

PAVM beat 13 of 35 last estimates.

37%

Next Report

Date of Next Report
Mar 23, 2026
Estimate for Q4 25 (Revenue/ EPS)
$51.00K
/
-$5.50
Implied change from Q3 25 (Revenue/ EPS)
+920.00%
/
-36.71%
Implied change from Q4 24 (Revenue/ EPS)
+410.00%
/
-2064.29%

PAVmed Inc. Common Stock earnings per share and revenue

On Nov 12, 2025, PAVM reported earnings of -8.69 USD per share (EPS) for Q3 25, missing the estimate of -5.20 USD, resulting in a -67.24% surprise. Revenue reached 5.00 thousand, compared to an expected 25.50 thousand, with a -80.39% difference. The market reacted with a -8.49% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analysts forecast an EPS of -5.50 USD, with revenue projected to reach 51.00 thousand USD, implying an decrease of -36.71% EPS, and increase of 920.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
AngioDynamics, Inc.
Report Date
Jan 06, 2026 For Q2 26
Estimate
-$0.10
Actual
$0.00
Surprise
+100.00%
FAQ
For Q3 2025, PAVmed Inc. Common Stock reported EPS of -$8.69, missing estimates by -67.24%, and revenue of $5.00K, -80.39% below expectations.
The stock price moved down -8.49%, changed from $0.39 before the earnings release to $0.35 the day after.
The next earning report is scheduled for Mar 23, 2026.
Based on 4 analysts, PAVmed Inc. Common Stock is expected to report EPS of -$5.50 and revenue of $51.00K for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement